Skip to main content
. 2023 Sep 13;8(10):1334–1353. doi: 10.1016/j.jacbts.2023.06.005

Table 1.

Clinical Characteristics of the Study Groups

Young (n = 100) Elderly (n = 109) P Value
Age, y 29 (25-33) 72 (68-76) <0.001
Male 49 (49) 45 (41) 0.32
Height, cm 172 (167-180) 160 (156-169) <0.001
Weight, kg 69 (60-84) 77 (67-87) 0.046
BMI, kg/m2 23.0 (21.1-26.0) 28.0 (25.7-31.0) <0.001
BSA, m2 1.8 (1.7-2.0) 1.8 (1.7-2.0) 0.84
Hypertension 9 (9) 66 (61) <0.001
Hyperlipidemia 6 (6) 25 (23) <0.001
Diabetes mellitus 1 (1) 20 (18) <0.001
Former smokers 51 (51) 41 (38) 0.071
Current smokers 32 (32) 5 (5) <0.001
Creatinine, μmol/L 75 (61-85) 80 (68-91) 0.020
GFR, mL/min/1.73 m2 98 (83-108) 72 (59-80) <0.001
Glucose, mmol/L 5.2 (4.9-5.7) 5.7 (5.3-6.5) <0.001
HbA1c (n = 204), % 5.3 (5.1-5.5) 5.8 (5.5-6.1) <0.001
Triglyceride, mmol/L 1.2 (0.8-1.8) 2.0 (1.5-2.9) <0.001
Total cholesterol, mmol/L 4.9 ± 0.9 5.8 ± 1.0 <0.001
LDL-C (n = 199), mmol/L 2.8 (2.3-3.3) 3.6 (3.1-4.1) <0.001
HDL-C, mmol/L 1.5 (1.2-1.8) 1.4 (1.2-1.7) 0.17
ASAT, U/L 18 (16-21) 19 (16-23) 0.21
ALAT, U/L 16.5 (13.0-23.0) 16.0 (13.0-21.0) 0.92
GGT, U/L 13 (10-22) 21 (14-31) <0.001
ALP, U/L 63 (53-78) 74 (63-89) <0.001
hs-CRP (n = 208), mg/L 1.0 (0.5-2.8) 2.2 (1.1-4.9) <0.001
NT-proBNP (n = 205), pg/mL 33 (15-60) 99 (69-209) <0.001
CIMT (n = 174), mm 0.6 (0.6-0.6) 0.9 (0.9-1.0) <0.001
PCSK9, ng/mL 188 (156-211) 236 (202-279) <0.001

Values are median (IQR), n (%), or mean ± SD. The characteristics of the 2 groups were compared using unpaired Student’s t test or Mann-Whitney U test for continuous variables and chi-square or Fisher exact test for categorical variables, as appropriate.

ALAT = alanine aminotransferase; ALP = alkaline phosphatase; ASAT = aspartate aminotransferase; BMI = body mass index; BSA = body surface area; CIMT = maximal carotid intima-media thickness; GFR = glomerular filtration rate; GGT = gamma-glutamyltransferase; HbA1c = glycosylated hemoglobin; HDL-C = high-density lipoprotein cholesterol; hs-CRP = high-sensitivity C-reactive protein; LDL-C = low-density lipoprotein cholesterol; NT-proBNP = N-terminal pro–B-type natriuretic peptide; PCSK9 = proprotein convertase subtilisin/kexin type 9.